Teaching health centres.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 4649215)

Published in Med J Aust on December 02, 1972

Authors

N A Andersen, W L Corlis, A E Davis, W B Hennessy, M Latham, H G Norton, F F Rundle, H M Saxby, G D Tracy

Articles by these authors

(truncated to the top 100)

Recurrent Retinal Hemorrhages Occurring in the Young, with the Report of a Case. Trans Am Ophthalmol Soc (1912) 3.44

A third way: beyond incremental reform of the Australian health economy. Aust Health Rev (1994) 2.04

Campylobacter pyloridis gastritis II: Distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol (1987) 1.98

Neutralization test in influenza: use in individuals without hemagglutination inhibition antibody. J Clin Microbiol (1979) 1.97

Structural and functional division into two domains of the large (100- to 115-kDa) chains of the clathrin-associated protein complex AP-2. Proc Natl Acad Sci U S A (1989) 1.91

Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A (1989) 1.73

Patients attending an accident and emergency department for primary medical care. Fam Pract (1984) 1.48

The prevention of hospitalization in schizophrenia: five years after an experimental program. Am J Orthopsychiatry (1972) 1.45

Evaluation of the Honeywell ACS 1000. Am J Med Technol (1977) 1.40

Medical aspects of euthanasia. Med J Aust (1992) 1.39

The blunt edge of the Baume report. Med J Aust (1995) 1.38

Pre-operative chemo-radiotherapy in locally advanced rectal cancer: is this the way of future management? Australas Radiol (1999) 1.38

Heterogeneity of nephritic factor and its identification as an immunoglobulin. Proc Natl Acad Sci U S A (1977) 1.34

Purification and chemical composition of gpL115, the human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Biol Chem (1986) 1.33

Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g. J Immunol (1984) 1.32

Monotreme IGF2 expression and ancestral origin of genomic imprinting. J Exp Zool (2001) 1.28

Double-blind trial of cholestyramine in post-vagotomy diarrhoea. Gut (1977) 1.28

Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites. J Virol (1996) 1.27

Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long term use. Thorax (2001) 1.26

Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans. J Clin Invest (1977) 1.26

The effect of diet on lactase activity in the rat. Gastroenterology (1971) 1.19

Barth syndrome: clinical features and confirmation of gene localisation to distal Xq28. Am J Med Genet (1993) 1.11

Biosynthesis of complement by human monocytes. Clin Immunol Immunopathol (1981) 1.10

Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers. Gut (1973) 1.10

Structural characterization of factor I mediated cleavage of the third component of complement. Biochemistry (1982) 1.09

Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways. J Virol (1993) 1.09

Paramyosin is the Schistosoma mansoni (Trematoda) homologue of antigen B from Taenia solium (Cestoda). Mol Biochem Parasitol (1991) 1.08

Serum and Lens-Antigen Extract Treatment for the Prevention and Cure of Cataract: With the Report of the Results Obtained in One Hundred and Thirty-one Cataracts. Trans Am Ophthalmol Soc (1924) 1.07

A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J Biol Chem (1993) 1.06

Complement-dependent histaminase release from human granulocytes. J Clin Invest (1979) 1.04

Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11. Proc Natl Acad Sci U S A (1986) 1.03

Lactose intolerance in Singapore. Gastroenterology (1970) 1.02

Ultrastructure and composition of bovine conglutinin. Biochem J (1986) 1.02

The C5a receptor is expressed by human renal proximal tubular epithelial cells. Clin Exp Immunol (2000) 1.02

Bovine conglutinin is a collagen-like protein. Biochemistry (1984) 1.02

Activation of extracellular signal-regulated kinase (ERK)1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic beta-cells. Eur Cytokine Netw (2000) 1.01

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol (1994) 1.01

Renal allograft rupture: cause, clinical features and management. Ann Surg (1973) 1.00

Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma. Eur Cytokine Netw (2000) 0.99

Effects of ethyl alcohol on sphincteric resistance at the choledocho-duodenal junction in man. Gut (1968) 0.98

Lactose intolerance in asians. Nature (1967) 0.98

Angioedema induced by a peptide derived from complement component C2. J Exp Med (1988) 0.97

Suppression of rejection of Nippostrongylus brasiliensis in iron and protein deficient rats: effect of syngeneic lymphocyte transfer. Gut (1978) 0.97

Regulation of C1 inhibitor synthesis. Immunobiology (1998) 0.95

Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema. J Clin Invest (1987) 0.95

Homozygous C3 deficiency: detection of C3 by radioimmunoassay. Clin Immunol Immunopathol (1977) 0.94

Histopathology in giardiasis: a correlation with diarrhoea. Aust N Z J Med (1978) 0.94

C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis. Clin Exp Immunol (2002) 0.94

Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site. Proc Natl Acad Sci U S A (1990) 0.93

Recombinations between Alu repeat sequences that result in partial deletions within the C1 inhibitor gene. Genomics (1990) 0.93

Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children. Clin Nephrol (1978) 0.93

Are general practitioners in favour of quality assurance? Aust Fam Physician (1989) 0.92

The histopathological changes in the thymus gland in the acquired immune deficiency syndrome. Ann N Y Acad Sci (1984) 0.92

Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG? N Engl J Med (1977) 0.91

Natural history of blue sclerae in osteogenesis imperfecta. Am J Med Genet (1993) 0.91

Association of alternative complement pathway components with human blood platelets: secretion and localization of factor D and beta 1H Globulin. Clin Immunol Immunopathol (1981) 0.91

Human factor D of the alternative complement pathway. Physicochemical characteristics and N-terminal amino acid sequence. Biochemistry (1979) 0.90

Localization of the human complement component C3 binding site on the IgG heavy chain. J Biol Chem (1991) 0.90

Gangrene of the tongue caused by temporal arteritis. Med J Aust (1966) 0.90

The C3b inactivator of the human complement system: homology with serine proteases. FEBS Lett (1981) 0.89

Lactose intolerance in various ethnic groups in South-East Asia. Australas Ann Med (1968) 0.88

Adaptation of intestinal lactase in the rat. Gastroenterology (1969) 0.88

Frequency and etiology of gross hematuria in a general pediatric setting. Pediatrics (1977) 0.88

Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein. J Clin Invest (1995) 0.87

Cimetidine and acute upper gastrointestinal bleeding: a double-blind controlled trial. Aust N Z J Med (1980) 0.87

Hemispheric asymmetry: frequency analysis of visual and auditory evoked responses to non-verbal stimuli. Electroencephalogr Clin Neurophysiol (1974) 0.87

Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene. Proc Natl Acad Sci U S A (1990) 0.87

Surveillance nurse helps infection control. Mod Hosp (1966) 0.87

Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon. J Clin Invest (1989) 0.87

Transcriptional regulation of the C1 inhibitor gene by gamma-interferon. J Biol Chem (1994) 0.86

Effects of nitrite exposure on blood respiratory properties, acid-base and electrolyte regulation in the carp (Cyprinus carpio). J Comp Physiol B (1987) 0.86

Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edema. Hum Genet (1994) 0.86

Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema. J Clin Invest (1987) 0.86

The effects of ethyl alcohol on pancreatic exocrine function. Med J Aust (1966) 0.85

Preventing feeding-associated aspiration. Medsurg Nurs (1995) 0.85

Coeliac artery compression. Br J Surg (1980) 0.85

Cooperative interaction of factor B and other complement components with mononuclear cells in the antibody-independent lysis of xenogeneic erythrocytes. J Exp Med (1982) 0.84

Functional analysis of the serpin domain of C1 inhibitor. J Immunol (1994) 0.84

Modification of macrophage response to lipopolysaccharide by fetuin. Immunol Lett (1998) 0.84

Cultured human glomerular mesangial cells express the C5a receptor. Kidney Int (1998) 0.84

Effect of pressure on the integrity of the duct-acinar system of the pancreas. Gut (1970) 0.84

Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing sera. J Immunol (1977) 0.84

Immunization against influenza in children with cancer: results of a three-dose trial. J Infect Dis (1982) 0.84

Non-invasive ventilation in the treatment of ventilatory failure following corrective spinal surgery. Anaesthesia (2001) 0.83

The effect of protein deficiency on systemic release of rat mucosal mast cell protease II during Nippostrongylus brasiliensis infection and following systemic anaphylaxis. Immunol Cell Biol (1987) 0.83

A cluster of mutations within a short triplet repeat in the C1 inhibitor gene. Proc Natl Acad Sci U S A (1994) 0.83

Speech dominance and handedness in the normal human. Brain Lang (1978) 0.83

Effect of iron and protein deficiency on the expulsion of Nippostrongylus brasiliensis from the small intestine of the rat. Gut (1977) 0.83

Characterization of new polymorphisms in the 5' UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level. Genes Immun (2000) 0.83

Effects of intravenous alcohol on motility of the duodenum and of the sphincter of Oddi. Australas Ann Med (1970) 0.83

Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4. J Gen Virol (1997) 0.82

Peripheral ischaemia caused by blood hyperviscosity. Aust N Z J Surg (1973) 0.82

Molecular defects in hereditary angioneurotic edema. Proc Assoc Am Physicians (1997) 0.82

Properdin factor D: effects on thrombin-induced platelet aggregation. J Clin Invest (1979) 0.82

Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema. J Clin Invest (1991) 0.81

Primary lactase deficiency: genetic or acquired? Am J Dig Dis (1970) 0.81

Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema. J Clin Invest (1991) 0.81

Active site amino acid sequence of human factor D. Proc Natl Acad Sci U S A (1980) 0.81

Hospital disinfection of thermometers. Superv Nurse (1975) 0.81

Insulin stimulates dephosphorylation of phosphorylase in rat epitrochlearis muscles. J Biol Chem (1989) 0.81